Download PDF
Thromb Haemost 2014; 112(03): 621-623
DOI: 10.1160/TH13-10-0851
Letters to the Editor
Schattauer GmbH

Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal

Francesco Dentali
1   Department of Clinical Medicine Insubria University, Varese, Italy
,
Davide Imberti
2   Haemostasis and Thrombosis Center, Department of Internal Medicine, Piacenza Hospital, Piacenza, Italy
,
Eleonora Tamburini Permunian
1   Department of Clinical Medicine Insubria University, Varese, Italy
,
Ezio Croci
3   Clinical Pathology, Piacenza Hospital, Piacenza, Italy
,
Walter Ageno
1   Department of Clinical Medicine Insubria University, Varese, Italy
› Author Affiliations
Further Information

Publication History

Received: 15 October 2013

Accepted after major revision: 23 April 2014

Publication Date:
20 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Ageno W, Gallus AS, Wittkowsky A. et al. American College of Chest Physicians. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) Suppl e44S-488S.
    CrossrefPubMedGoogle Scholar
  • 2 Palareti G, Leali N, Coccheri S. et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
    CrossrefPubMedGoogle Scholar
  • 3 Ageno W, Garcia D, Aguilar MI. et al. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. Am J Hematol 2009; 84: 584-588.
    CrossrefPubMedGoogle Scholar
  • 4 Libby EN, Garcia DA. A survey of oral vitamin K use by anticoagulation clinics. Arch Intern Med 2002; 162: 1893-1896.
    CrossrefPubMedGoogle Scholar
  • 5 Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 2006; 04: 1853-1863.
    CrossrefPubMedGoogle Scholar
  • 6 Samama CM. Prothrombin complex concentrates: a brief review. Eur J Anaesthesiol 2008; 25: 784-789.
    CrossrefPubMedGoogle Scholar
  • 7 Dentali F, Marchesi C, Pierfranceschi MG. et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 2011; 106: 429-438.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Baggs JH, Patanwala AE, Williams EM. et al. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal. Ann Pharmacother 2012; 46: 51-56.
    CrossrefPubMedGoogle Scholar
  • 9 Holland L, Warkentin TE, Refaai M. et al. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supra-therapeutic international normalized ratio due to warfarin overdose. Transfusion 2009; 49: 1171-1177.
    CrossrefPubMedGoogle Scholar
  • 10 Imberti D, Magnacavallo A, Dentali F. et al. Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding. J Thromb Thrombolysis 2013; 36: 102-108.
    CrossrefPubMedGoogle Scholar
  • 11 Imberti D, Barillari G, Biasioli C. et al. Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage. Pathophysiol Haemost Thromb 2008; 36: 259-265.
    PubMedGoogle Scholar
  • 12 Menzin J, Hoesche J, Friedman M. et al. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. J Thromb Haemost 2012; 10: 596-605.
    CrossrefPubMedGoogle Scholar